Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 12, Pages 3016
Publisher
MDPI AG
Online
2021-06-16
DOI
10.3390/cancers13123016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Screening for Lung Cancer
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Screening for Colon Cancer in Older Adults: Risks, Benefits, and When to Stop
- (2020) Judy Nee et al. MAYO CLINIC PROCEEDINGS
- A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
- (2020) Thomas Hermanns et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
- (2020) Tobias Fehlmann et al. JAMA Oncology
- DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types
- (2020) Vera Constâncio et al. Cells
- Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients
- (2020) Patricia M. M. Ozawa et al. Biomolecules
- Detection of promoter DNA methylation in urine and plasma aids the detection of non-small cell lung cancer
- (2020) Bin Liu et al. CLINICAL CANCER RESEARCH
- SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis
- (2020) Mehdi Manoochehri et al. Molecular Oncology
- Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
- (2020) Yi Liu et al. Frontiers in Genetics
- Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients
- (2020) Roxana Cojocneanu et al. Cancers
- Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
- (2020) M.C. Liu et al. ANNALS OF ONCOLOGY
- Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy
- (2020) Mohammad Reza Karimzadeh et al. CANCER GENE THERAPY
- Methods for analysis of specific DNA methylation status
- (2020) María J. Pajares et al. METHODS
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
- (2020) Pier Vitale Nuzzo et al. NATURE MEDICINE
- Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
- (2020) Farshad Nassiri et al. NATURE MEDICINE
- Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
- (2020) Xingdong Chen et al. Nature Communications
- Current status of development of methylation biomarkers for in vitro diagnostic IVD applications
- (2020) Olga Taryma-Leśniak et al. Clinical Epigenetics
- Aberrant DNA Methylation of SEPT9 and SDC2 in Stool Specimens as an Integrated Biomarker for Colorectal Cancer Early Detection
- (2020) Guodong Zhao et al. Frontiers in Genetics
- Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers
- (2020) Yung-Hung Luo et al. Cancers
- A Distinctive microRNA (miRNA) Signature in the Blood of Colorectal Cancer (CRC) Patients at Surgery
- (2020) Jessica Gasparello et al. Cancers
- Liquid biopsies and cancer omics
- (2020) Ivano Amelio et al. Cell Death Discovery
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Circulating Transcriptome as a Source of Biomarkers for Melanoma
- (2019) Carla Solé et al. Cancers
- Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations
- (2019) Haixin Yu et al. Cancers
- Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
- (2019) Marta Herreros-Villanueva et al. Clinical and Translational Gastroenterology
- Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
- (2019) Irene Li et al. Molecular Cancer
- Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
- (2019) Fumihiko Urabe et al. CLINICAL CANCER RESEARCH
- Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery
- (2019) Francisco Exposito et al. CANCER LETTERS
- A pilot study of new promising non-coding RNA diagnostic biomarkers for early-stage colorectal cancers
- (2019) Hanshao Liu et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Is global hypomethylation a nidus for molecular pathogenesis of age-related noncommunicable diseases?
- (2019) Apiwat Mutirangura Epigenomics
- Analysis of circulating non-coding RNAs in a non-invasive and cost-effective manner
- (2019) Yu-Min Wang et al. TRAC-TRENDS IN ANALYTICAL CHEMISTRY
- Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis
- (2019) Laura M. Doyle et al. Cells
- Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
- (2019) Giovanni Ponti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
- (2019) MaryBeth B. Culp et al. EUROPEAN UROLOGY
- Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening
- (2019) Guodong Zhao et al. Cancer Medicine
- Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
- (2019) Emre Özgür et al. Cancer Biomarkers
- Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer
- (2019) Jinshuo Fan et al. GENOMICS
- Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer
- (2019) Wei Xu et al. INTERNATIONAL JOURNAL OF CANCER
- DNA Methylation Cancer Biomarkers: Translation to the Clinic
- (2019) Warwick J. Locke et al. Frontiers in Genetics
- Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors
- (2019) Alena Kopkova et al. Cancers
- Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
- (2019) Helena Estevão-Pereira et al. Journal of Translational Medicine
- Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy
- (2019) Óscar Rapado-González et al. Cells
- The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
- (2018) Oliver A. Zill et al. CLINICAL CANCER RESEARCH
- Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA
- (2018) Lydia Giannopoulou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- GSTP1 methylation in cancer: a liquid biopsy biomarker?
- (2018) Giorgia Gurioli et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients
- (2018) Magdalena Absmaier et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition
- (2018) Paweł Porzycki et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- The Role of DNA Methylation in Renal Cell Carcinoma
- (2018) Brittany N. Lasseigne et al. Molecular Diagnosis & Therapy
- Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
- (2018) Christa Haldrup et al. Molecular Oncology
- Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer
- (2018) Yujiao Xie et al. Molecular Oncology
- The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
- (2018) Simon Ladefoged Rasmussen et al. Oncotarget
- A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples
- (2018) María Gallardo-Gómez et al. Clinical Epigenetics
- Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
- (2018) Yu Wang et al. World Journal of Gastrointestinal Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
- (2018) Jagdeep Singh Bhangu et al. ANNALS OF SURGERY
- Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection
- (2018) Maurizia Mello-Grand et al. CARCINOGENESIS
- Serum miRNA-based prediction of axillary lymph node metastasis in breast cancer
- (2018) Sho Shiino et al. CLINICAL CANCER RESEARCH
- A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
- (2018) Fang Zhao et al. Clinical Epigenetics
- Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients
- (2018) Catarina Moreira-Barbosa et al. Clinical Epigenetics
- Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
- (2018) Luis M. Seijo et al. Journal of Thoracic Oncology
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy
- (2017) Kim E.M. van Kessel et al. JOURNAL OF UROLOGY
- Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance
- (2017) Fang Zhao et al. JOURNAL OF UROLOGY
- Unlocking bladder cancer
- (2017) Chris Berdik NATURE
- The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection
- (2017) Tomasz Powrózek et al. PATHOLOGY RESEARCH AND PRACTICE
- Colorectal cancer screening: An updated review of the available options
- (2017) Iyad A Issa et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer
- (2017) Zhong-Hua Han et al. Oncology Letters
- Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients
- (2017) Mariana Brait et al. Oncotarget
- The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
- (2017) Qiliang Peng et al. Oncotarget
- Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer
- (2017) Lutao Du et al. Oncotarget
- The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis
- (2017) Di Liu et al. International Journal of Environmental Research and Public Health
- Circulating Tumor DNA as Biomarkers for Cancer Detection
- (2017) Xiao Han et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
- (2017) Peter McAnena et al. Cancers
- Amplification-Free Detection of Circulating microRNA Biomarkers from Body Fluids Based on Fluorogenic Oligonucleotide-Templated Reaction between Engineered Peptide Nucleic Acid Probes: Application to Prostate Cancer Diagnosis
- (2016) Gavin A. D. Metcalf et al. ANALYTICAL CHEMISTRY
- Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force
- (2016) Joy Melnikow et al. ANNALS OF INTERNAL MEDICINE
- Salivary DNA methylation panel to diagnose HPV-positive and HPV-negative head and neck cancers
- (2016) Yenkai Lim et al. BMC CANCER
- A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer
- (2016) A. Diaz-Lagares et al. CLINICAL CANCER RESEARCH
- Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
- (2016) Alicia Hulbert et al. CLINICAL CANCER RESEARCH
- SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer
- (2016) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- New Progress of Epigenetic Biomarkers in Urological Cancer
- (2016) Peng Wu et al. DISEASE MARKERS
- Circulating miR-210 as a diagnostic and prognostic biomarker for colorectal cancer
- (2016) W. Wang et al. EUROPEAN JOURNAL OF CANCER CARE
- Plasma and saliva miR-21 expression in colorectal cancer patients
- (2016) A. A. Sazanov et al. JOURNAL OF APPLIED GENETICS
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Downregulation of mir-23b in plasma is associated with poor prognosis in patients with colorectal cancer
- (2016) Chang-Hua Kou et al. Oncology Letters
- Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
- (2016) C. Alix-Panabieres et al. Cancer Discovery
- A microRNA biomarker panel for the non-invasive detection of bladder cancer
- (2016) Virginia Urquidi et al. Oncotarget
- Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma
- (2016) Xujie Gao et al. Oncotarget
- A cross-sectional study comparing a blood test for methylatedBCAT1 and IKZF1tumor-derived DNA with CEA for detection of recurrent colorectal cancer
- (2016) Graeme P. Young et al. Cancer Medicine
- Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection
- (2016) Perry J. Pickhardt Abdominal Radiology
- Considering Exosomal miR-21 as a Biomarker for Cancer
- (2016) Jian Shi Journal of Clinical Medicine
- Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests
- (2016) Le-Le Song et al. World Journal of Gastrointestinal Oncology
- Plasma extracellular RNA profiles in healthy and cancer patients
- (2016) Tiezheng Yuan et al. Scientific Reports
- A urine-based methylation signature for risk stratification within low-risk prostate cancer
- (2015) T A Jatkoe et al. BRITISH JOURNAL OF CANCER
- Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer
- (2015) T F Hansen et al. BRITISH JOURNAL OF CANCER
- Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients
- (2015) T. Powrózek et al. Clinical & Translational Oncology
- Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
- (2015) Shuhang Wang et al. Journal of Hematology & Oncology
- Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer
- (2015) Deyuan Fu et al. MEDICINE
- MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer
- (2015) David A. Armstrong et al. Molecular Cancer
- Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis
- (2015) Sanaa Eissa et al. TUMOR BIOLOGY
- An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese
- (2015) Yongqiang Wang et al. Oncotarget
- miRNA in situ hybridization in circulating tumor cells - MishCTC
- (2015) Francisco G. Ortega et al. Scientific Reports
- Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
- (2015) Hong Wang et al. Clinical Epigenetics
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- ESR1gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
- (2014) Joaquina Martínez-Galán et al. BMC CANCER
- Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
- (2014) I Balgkouranidou et al. BRITISH JOURNAL OF CANCER
- HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients
- (2014) M. Svoboda et al. CARCINOGENESIS
- A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer
- (2014) Garima Sharma et al. CURRENT GENOMICS
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- Septin 9 promoter region methylation in free circulating DNA—potential role in noninvasive diagnosis of lung cancer: preliminary report
- (2014) Tomasz Powrózek et al. MEDICAL ONCOLOGY
- Circulating microRNAs as a Fingerprint for Endometrial Endometrioid Adenocarcinoma
- (2014) Lin Wang et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
- (2014) A. B. Miller et al. BMJ-British Medical Journal
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Clinical Significance of CDH13 Promoter Methylation in Serum Samples from Patients with Bladder Transitional Cell Carcinoma
- (2013) YL Lin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer
- (2013) YL Lin et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer
- (2013) Zhen-Guo Luo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy
- (2013) Yi-Teng Huang et al. Journal of Translational Medicine
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells
- (2013) Maria Chimonidou et al. MOLECULAR CANCER RESEARCH
- The Prognostic Value of p16 Hypermethylation in Cancer: A Meta-Analysis
- (2013) Xiang-Bin Xing et al. PLoS One
- CST6 promoter methylation in circulating cell-free DNA of breast cancer patients
- (2012) Maria Chimonidou et al. CLINICAL BIOCHEMISTRY
- SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer
- (2012) M. Chimonidou et al. CLINICAL CHEMISTRY
- Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma
- (2012) Jing Shen et al. Epigenetics
- Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals
- (2012) H. Tani et al. GENOME RESEARCH
- Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer
- (2012) Qifeng Wang et al. PLoS One
- Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
- (2012) Thomas Reinert et al. PLoS One
- Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay
- (2011) Noriaki Yamamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis
- (2011) T Wu et al. BRITISH JOURNAL OF CANCER
- Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
- (2011) J. S. McDonald et al. CLINICAL CHEMISTRY
- Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis
- (2011) Xi Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial-Specific Methylation Marker: A Potential Plasma Biomarker in Advanced Non-small Cell Lung Cancer
- (2011) Chanida Vinayanuwattikun et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing a Blood-Based Test in Breast Cancer
- (2011) Ramin Radpour et al. PLoS One
- Correction: Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis
- (2011) Hector Alvarez et al. PLoS Genetics
- Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR
- (2010) K. L. Ostrow et al. CLINICAL CANCER RESEARCH
- DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening
- (2010) N. Shivapurkar et al. CURRENT MOLECULAR MEDICINE
- First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
- (2010) Fernanda Salazar et al. LUNG CANCER
- Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
- (2010) B.-L. Liu et al. NEURO-ONCOLOGY
- Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression
- (2010) Gayatri Sharma et al. TUMOR BIOLOGY
- Hypomethylation of repeated DNA sequences in cancer
- (2010) Jason P Ross et al. Epigenomics
- Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
- (2009) E. Sunami et al. CLINICAL CHEMISTRY
- Sensitive digital quantification of DNA methylation in clinical samples
- (2009) Meng Li et al. NATURE BIOTECHNOLOGY
- DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection
- (2009) Shannon R. Payne et al. PROSTATE
- Development of a Multiplexed Urine Assay for Prostate Cancer Diagnosis
- (2008) T. Vener et al. CLINICAL CHEMISTRY
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started